Ampio Pharmaceuticals, Inc. Gains 28.32%
Wed, Nov 16, 2022 at 07:29 PM
Ampio Pharmaceuticals, Inc. (AMPE:NYSEMKT) soared at $0.03, representing a gain of 28.3%. On Wed, Nov 16, 2022, AMPE:NYSEMKT hit a New 2-Week Intraday Low of $0.02. The stock got featured on our News Catalysts scanner on Tue, Nov 08, 2022 at 07:22 PM in the 'SPLIT' category. From Wed, Nov 02, 2022, the stock recorded 10.00% Up Days and 27.27% Green Days
About Ampio Pharmaceuticals, Inc. (AMPE:NYSEMKT)
Ampio Pharmaceuticals Inc is a biopharmaceutical company. The company is engaged in the development of therapies to treat prevalent inflammatory conditions for which there are limited treatment options.
Top 10 Gainers:
- Fast Radius Inc. (FSRD:NASDAQ), 106.29%
- InMed Pharmaceuticals Inc. (INM:NASDAQ), 36.33%
- Foresight Autonomous Holdings Ltd. (FRSX:NASDAQ), 33.04%
- XL Group Ltd (XL:NYSE), 30.91%
- Ensysce Biosciences Inc. (ENSC:NASDAQ), 29.17%
- Ampio Pharmaceuticals, Inc. (AMPE:NYSEMKT), 28.32%
- Creatd Inc. (CRTD:NASDAQ), 22.12%
- Allied Healthcare Products, Inc. (AHPI:NASDAQ), 21.99%
- BYND Cannasoft Enterprises Inc. (BCAN:NASDAQ), 19.67%
- Oncorus Inc. (ONCR:NASDAQ), 18.61%